These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3898491)

  • 21. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A; Druskis V; Laurinavicius A
    Clin Nephrol; 2001 Dec; 56(6):S27-9. PubMed ID: 11770808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and Long-Term Safety and Tolerability of Everolimus in Renal Transplant Recipients Converted From Cyclosporine.
    Felipe CR; Oliveira NI; Hannun PG; de Paula MI; Tedesco-Silva H; Medina-Pestana JO
    Ther Drug Monit; 2016 Feb; 38(1):64-72. PubMed ID: 26274696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.
    Porayko MK; Textor SC; Krom RA; Hay JE; Gores GJ; Richards TM; Crotty PH; Beaver SJ; Steers JL; Wiesner RH
    Mayo Clin Proc; 1994 Feb; 69(2):105-11. PubMed ID: 7508536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of the conventional and microemulsion formulations of cyclosporine in pancreas-kidney transplant recipients with gastroparesis.
    van der Pijl JW; Srivastava N; Denouël J; Burggraaf J; Schoemaker RC; van der Woude FJ; Cohen AF
    Transplantation; 1996 Aug; 62(4):456-62. PubMed ID: 8781610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.
    Aleksic I; Baryalei M; Busch T; Pieske B; Schorn B; Strauch J; Sîrbu H; Dalichau H
    Transplantation; 2000 Apr; 69(8):1586-90. PubMed ID: 10836367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients.
    Lorber MI; Van Buren CT; Flechner SM; Williams C; Kahan BD
    Transplantation; 1987 Jan; 43(1):35-40. PubMed ID: 3541320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients.
    Sagedal S; Asberg A; Hartmann A; Bergan S; Berg KJ
    Clin Transplant; 1998 Dec; 12(6):553-6. PubMed ID: 9850449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensive prolongation of rat renal allograft survival following donor or nonspecific transfusions and concomitant immunosuppressant.
    Martin DC; Hewitt CW; Black KS; Dowdy SF; Quintero CS; Reyes M
    Transplantation; 1987 Jun; 43(6):790-4. PubMed ID: 3296345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal graft function and low-dose cyclosporine affect mycophenolic acid pharmacokinetics in kidney transplantation.
    Cortinovis M; Gotti E; Pradini S; Gaspari F; Perico N
    Transplantation; 2011 Sep; 92(5):550-6. PubMed ID: 21709602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients.
    Falck P; Vethe NT; Asberg A; Midtvedt K; Bergan S; Reubsaet JL; Holdaas H
    Nephrol Dial Transplant; 2008 Mar; 23(3):1048-53. PubMed ID: 17956893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
    Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. von Willebrand factor and factor VIII in renal transplant recipients under immunosuppression with cyclosporine and steroids. Sequential measurements over 4 months in 17 patients.
    Huser B; Lämmle B; Landmann J; Tran TH; Oberholzer M; Marbet GA; Thiel G; Mihatsch MJ; Duckert F
    Clin Nephrol; 1990 Nov; 34(5):214-22. PubMed ID: 2125251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study.
    Wu X; Li Q; Xin H; Yu A; Zhong M
    Eur J Clin Pharmacol; 2005 Sep; 61(8):567-72. PubMed ID: 16133554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients.
    Falck P; Asberg A; Byberg KT; Bremer S; Bergan S; Reubsaet JL; Midtvedt K
    Transplantation; 2008 Nov; 86(10):1379-83. PubMed ID: 19034006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of steady-state cyclosporine concentrations on renal allograft outcome.
    Dunn J; Grevel J; Napoli K; Lewis RM; Van Buren CT; Kahan BD
    Transplantation; 1990 Jan; 49(1):30-4. PubMed ID: 2301023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between area under the concentration versus time curve of cyclosporin A, creatinine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients.
    Shibata N; Hoshino N; Minouchi T; Yamaji A; Park K; Tomoyoshi T; Abe H; Kodama M
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):202-9. PubMed ID: 9587046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion from cyclosporine to azathioprine in renal graft recipients.
    MacDonald AS; Belitsky P; Gupta R; Bitter-Suermann H; Campbell R; Cohen A; Lannon SG
    Transplant Proc; 1985 Aug; 17(4):1940-2. PubMed ID: 3895634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
    Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
    Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.